Logo image of AUPH

AURINIA PHARMACEUTICALS INC (AUPH) Stock Analyst Ratings

NASDAQ:AUPH - Nasdaq - CA05156V1022 - Common Stock - Currency: USD

7.93  +0.1 (+1.28%)

After market: 7.93 0 (0%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to AUPH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.02. This target is 39.02% above the current price.
AUPH was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AUPH.
In the previous month the buy percentage consensus was at a similar level.
AUPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
AUPH Historical Analyst RatingsAUPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15

Price Target & Forecast

Price Low Median Mean High 7.938.0811.6511.0213.65 - 1.89% 46.95% 39.02% 72.13%
AUPH Current Analyst RatingAUPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-23 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-02-22 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-16 RBC Capital Maintains Outperform -> Outperform
2023-09-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-07-06 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-05-03 HC Wainwright & Co. Reiterate Buy
2023-02-23 RBC Capital Reiterate Outperform
2023-01-04 RBC Capital Maintains Outperform
2022-11-07 HC Wainwright & Co. Maintains Buy
2022-11-04 Oppenheimer Downgrade Outperform -> Perform
2022-11-04 RBC Capital Maintains Outperform
2022-11-04 SVB Leerink Maintains Outperform
2022-08-09 HC Wainwright & Co. Maintains Buy
2022-08-08 Oppenheimer Maintains Outperform
2022-05-05 HC Wainwright & Co. Maintains Buy
2022-04-28 RBC Capital Maintains Outperform
2022-03-08 SVB Leerink Maintains Outperform
2022-03-01 RBC Capital Maintains Outperform
2022-02-23 RBC Capital Maintains Outperform
2021-12-10 Oppenheimer Upgrade Perform -> Outperform
2021-11-04 Oppenheimer Maintains Perform
2021-11-04 SVB Leerink Maintains Outperform
2021-11-04 HC Wainwright & Co. Maintains Buy
2021-10-28 Oppenheimer Downgrade Outperform -> Perform
2021-10-26 RBC Capital Maintains Outperform